Vote Scores

Home / Companies / United Therapeutics Corporation / 26 Jun 2026

Meeting · year to 30 June 2026907 filers reporting

United Therapeutics Corporation: meeting of 26 Jun 2026

Votes reported on Form N-PX, item by item

907 Form N-PX filers reported votes at the United Therapeutics Corporation meeting of 26 Jun 2026. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

12 nominees; 94.6% of reported votes for; 38 filers withheld from or voted against at least one nominee.

8,366 vote records from 261 filers. 3 of the 260 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

97.7% for0.8% against1.5% other1.2% against management261 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

1,557 vote records from 901 filers. 40 of the 867 filers that marked the item either way voted against management. 34 filers reported this item without a management mark.

90.5% for4.3% against5.2% other4.6% against management901 filers97.5% for1.9% against0.6% other1.9% against management46,084,467 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

699 vote records from 261 filers. 2 of the 260 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

98.5% for0.8% against0.8% other0.8% against management261 filers99.8% for0.2% against0.1% other0.1% against management15,367,186 reported shares
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

706 vote records from 259 filers. 92 of the 258 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

62.5% for36.3% against1.2% other35.7% against management259 filers86.0% for14.0% against0.0% other13.8% against management15,376,635 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalForForFor
State Street and SPDRForForFor
American CenturyForAgainst *For
Franklin TempletonForForFor
InvescoForForFor
EquitableForForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
ProShares and ProFundsForForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertForForFor
J.P. MorganForForFor
Goldman SachsForForFor
WisdomTreeForForFor
PGIM and PrudentialForForFor
Jackson National fundsForForFor
Northern Trust and FlexSharesForForFor
SEIForForFor
T. Rowe PriceForForFor
ThriventForForFor
Lincoln FinancialForForFor
VoyaForForFor
First TrustForForFor
Russell InvestmentsForForFor
NationwideForForFor
Victory CapitalForForFor
Brighthouse FundsForForFor
Guggenheim and RydexForForFor
Columbia ThreadneedleForForFor
BNY MellonForForFor
PrincipalForForFor
Pacific Life fundsForForFor
Global XForForFor
TransamericaForForFor
Federated HermesForForFor
AllianceBernsteinForForFor
Hartford FundsForForFor
DWSForForFor
PIMCOForForFor
AllspringForForFor
MassMutualForForFor
Harbor FundsForForFor
VanEckForForFor
Macquarie and Delaware FundsForForFor
Janus HendersonForForFor
Neuberger BermanNo reportForNo report
Natixis and Loomis SaylesForForFor
Lord AbbettForForFor
BairdNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the United Therapeutics Corporation meeting?

907 Form N-PX filers reported votes at the meeting of 26 Jun 2026. On say-on-pay, 40 of 867 voted against management (4.6%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by United Therapeutics Corporation on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for United Therapeutics Corporation

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing United Therapeutics Corporation with a meeting date within three days of 26 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.